Thanks for the suggestion of HNU.TO! I will check into that when my hands are free. There is continuous work to be done for my current holdings and I am tied up with those at the moment.
I did not close DVAX on the way up but down (off more than a point on 25K shares, letting too much profits vanish) for a number of reasons:
1) I was expecting FDA's lifting of Heplisav clinical ban and I was right at that, the stock did soar on that news;
2) I was expecting the stock to move above 4/5 on that news but it did not, I was wrong in my pps expectation and badly disappointed. I did not anticipate market movements but took whatever it had to offer. When the offer was not in line with my expectations, I closed out;
3) I was expecting a PA announcement shortly after the news for Heplisav, that did not materialize. DVAX initiated the 600-people trial on its own. That trial will take at least two years to complete. Add in the lot-to-lot trial it is going to conduct, the costs will be very high relative to its cash position. Without a PA, DVAX is subject to issuing new shares --- dilution;
4) With the focus on Heplisav trials, DVAX may not initiate the universal flu trials as planned and announced earlier; and finally
5) I need capital for my perceived better competing use. I can't afford to lock up a big chunk of capital in "dead money".
These are my own reasonings. I have been wrong many times before and I will be wrong many times going forward. I was willing to take the risk of missing a DVAX surprise run.
I did not close DVAX on the way up but down (off more than a point on 25K shares, letting too much profits vanish) for a number of reasons:
1) I was expecting FDA's lifting of Heplisav clinical ban and I was right at that, the stock did soar on that news;
2) I was expecting the stock to move above 4/5 on that news but it did not, I was wrong in my pps expectation and badly disappointed. I did not anticipate market movements but took whatever it had to offer. When the offer was not in line with my expectations, I closed out;
3) I was expecting a PA announcement shortly after the news for Heplisav, that did not materialize. DVAX initiated the 600-people trial on its own. That trial will take at least two years to complete. Add in the lot-to-lot trial it is going to conduct, the costs will be very high relative to its cash position. Without a PA, DVAX is subject to issuing new shares --- dilution;
4) With the focus on Heplisav trials, DVAX may not initiate the universal flu trials as planned and announced earlier; and finally
5) I need capital for my perceived better competing use. I can't afford to lock up a big chunk of capital in "dead money".
These are my own reasonings. I have been wrong many times before and I will be wrong many times going forward. I was willing to take the risk of missing a DVAX surprise run.
I enjoy reading your writing, and it is kind of creative.
I noticed you closed your DVAX position, and could you please let us know the reason?
I bought hnu.to(gas.to) since it is said that this winter would be very cold, and the gas price is very low. What do you think?
Thanks.
